新規登録 | ログイン | FAQ      [?] 

Current Drug Discovery Technologies

最近発刊の雑誌の目次より: Current Drug Discovery Technologies © Bentham Science Publishers
  • High-Throughput Screening Assays to Discover Small-Molecule Inhibitors of Protein Interactions
    Current Drug Discovery Technologies, Vol. 5, No. 3. (September 2008), pp. 190-199.
  • Activity Based Chemical Proteomics: Profiling Proteases as Drug Targets
    Current Drug Discovery Technologies, Vol. 5, No. 3. (September 2008), pp. 200-212.
  • Current Topics of Organic and Biological Chemistry of Annonaceous Acetogenins and their Synthetic Mimics
    Current Drug Discovery Technologies, Vol. 5, No. 3. (September 2008), pp. 213-229.
  • SNP Technologies for Drug Discovery: A Current Review
    Current Drug Discovery Technologies, Vol. 5, No. 3. (September 2008), pp. 230-235.
  • Advances in Drug Discovery to Assess Cholinergic Neurotransmission: A Systematic Review
    Current Drug Discovery Technologies, Vol. 5, No. 3. (September 2008), pp. 236-249.
    by Ferreira, F Vitor, Da Rocha, R David, Lima Araujo, G Katia, Santos, C Wilson
  • Translation of New Technologies: From Basic Research to Drug Discovery and Development
    Current Drug Discovery Technologies, Vol. 5, No. 3. (September 2008), pp. 250-262.
  • RANKL/RANK/OPG: Key Therapeutic Target in Bone Oncology
    Current Drug Discovery Technologies, Vol. 5, No. 3. (September 2008), pp. 263-268.
  • Editorial [Hot Topic: Supramolecular Transmembrane Nanocarriers for Targeted Therapeutics (Guest Editor: Grzegorz Bazylak) ]
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 85-85.
  • Artificial Anion Transporters in Bilayer Membranes
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 86-97.
  • Functionalized Calix[n]arenes as Membrane Transporters for Biological Compounds.A Minireview
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 98-104.
  • Supramolecular Chiro-Biomedical Assays and Enantioselective HPLC Analyses for Evaluation of Profens as Non-Steroidal Anti-Inflammatory Drugs, Potential Anticancer Agents and Common Xenobiotics
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 105-120.
  • The Impact of Supramolecular Nanocarriers to Contemporary Pharmaceutical and Analytical Chemistry: A Minireview
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 121-128.
  • Effect of para-Sulfonato-Calix[n]arenes on the Solubility, Chemical Stability, and Bioavailability of a Water Insoluble Drug Nifedipine
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 129-139.
  • Solubilization and Stabilization of Sodium Dicloxacillin by Cyclodextrin Inclusion
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 140-145.
  • Thermodynamic Study of Cyclodextrins Complexation with Benzimidazolic Antihelmintics in Different Reaction Media
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 146-153.
  • First Divalent Metal Complexes of the Polyether Ionophore Monensin A:X-Ray Structures of [Co(Mon)2(H2O)2] and [Mn(Mon)2(H2O)2] and their Bactericidal Properties
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 154-161.
  • A Method to Evaluate a Propidium Iodide Association with Oligonucleotides and Oligonucleotide-Cationic Lipid Interactions
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 162-167.
  • Interactions of - and Hydroxypropyl--Cyclodextrin with Some Purine Alkaloids:Thermodynamic Study
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 168-172.
  • UV-vis Spectral Analysis of Inclusion Complexes between -Cyclodextrin and Aromatic/Aliphatic Guest Molecules
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 173-176.
  • Diversity Oriented High-Throughput Screening of 1,3,4-Oxadiazole Modified Chlorophenylureas and Halogenobenzamides by HPLC with Peptidomimetic Calixarene-Bonded Stationary Phases
    Current Drug Discovery Technologies, Vol. 5, No. 2. (June 2008), pp. 177-189.
  • Generation of Fusion Proteins for Selective Occlusion of Tumor Vessels
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 1-8.
  • Genomic Signatures for Individualized Treatment of Malignant Tumors
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 9-14.
  • Neurokinin Receptors as Potential Targets in Breast Cancer Treatment
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 15-19.
  • Biocombinatorial Selection of Carbohydrate Binding Agents of Therapeutic Significance
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 20-28.
  • Targeting Toll-Like Receptor Signaling Pathways for Design of Novel Immune Therapeutics
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 29-38.
  • Targeted Drug Delivery to Bone: Pharmacokinetic and Pharmacological Properties of Acidic Oligopeptide-Tagged Drugs
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 39-48.
  • MicroRNAs-Based Therapeutic Strategy for Virally Induced Diseases
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 49-58.
  • Current In Vitro Kinase Assay Technologies: The Quest for a Universal Format
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 59-69.
  • Emerging the Role of the Structure of Brain Membrane Targets Recognizing Glutamate
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 70-74.
  • Targeting Apoptosis to Treat Multiple Sclerosis
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 75-77.
  • Controlling Receptor Downregulation by Ubiquitination and Deubiquitination
    Current Drug Discovery Technologies, Vol. 5, No. 1. (March 2008), pp. 78-84.
  • Editorial [Hot Topic: Supramolecular Approaches for Improving Drug Delivery Processes (Guest Editor: Grzegorz Bazylak)]
    Current Drug Discovery Technologies, Vol. 4, No. 4. (December 2007), pp. i-i.
  • Recognition of Lysine Residues on Protein Surfaces Using Calixarenes and its Application
    Current Drug Discovery Technologies, Vol. 4, No. 4. (December 2007), pp. 220-228.
  • Surface Photochemistry: Organic Molecules within Nanocavities of Calixarenes
    Current Drug Discovery Technologies, Vol. 4, No. 4. (December 2007), pp. 229-245.
    by Vieira Ferreira, F Luis, Ferreira Machado, L Isabel
  • Design, Synthesis and Potent Pharmaceutical Applications of Glycodendrimers:A Mini Review
    Current Drug Discovery Technologies, Vol. 4, No. 4. (December 2007), pp. 246-254.
  • Supramolecular Systems-Based HPLC for Chiral Separation of Beta-Adrenergics and Beta-Adrenolytics in Drug Discovery Schemes
    Current Drug Discovery Technologies, Vol. 4, No. 4. (December 2007), pp. 255-274.
  • Thermal Properties and Microstructures of Methylated Polyrotaxane Solutions
    Current Drug Discovery Technologies, Vol. 4, No. 4. (December 2007), pp. 275-281.
  • Cyclodextrin Complexes: Chiral Recognition and Complexation Behaviour
    Current Drug Discovery Technologies, Vol. 4, No. 4. (December 2007), pp. 282-294.
  • 1H NMR Investigations of Inclusion Complexes Between -Cyclodextrin and 1-Hexadecanol
    Current Drug Discovery Technologies, Vol. 4, No. 4. (December 2007), pp. 295-297.
  • Predictive QSAR Modeling for the Successful Predictions of the ADMET Properties of Candidate Drug Molecules
    Current Drug Discovery Technologies, Vol. 4, No. 3. (October 2007), pp. 141-149.
  • Computational Analysis of Adhesion of Primer Ligands to Dentinal Collagen: Effect of Spacer Groups in Ligand and Amino Acid Residue Sequence Differences in Collagen
    Current Drug Discovery Technologies, Vol. 4, No. 3. (October 2007), pp. 150-161.
  • Biologic Aspects of Thrombopoietin and the Development of Novel Thrombopoietic Agents for Clinical Use
    Current Drug Discovery Technologies, Vol. 4, No. 3. (October 2007), pp. 162-173.
  • Alternative Splice Variants of Survivin as Potential Targets in Cancer
    Current Drug Discovery Technologies, Vol. 4, No. 3. (October 2007), pp. 174-191.
  • Influence of Sulfobutylether--Cyclodextrin on the Stability of S- and Romeprazole
    Current Drug Discovery Technologies, Vol. 4, No. 3. (October 2007), pp. 192-197.
  • Design and Synthesis of New N1 and C3-Substituted 4-Fluoroindolic Melatoninergics
    Current Drug Discovery Technologies, Vol. 4, No. 3. (October 2007), pp. 198-207.
  • Molecular Approaches to Cervical Cancer Therapy
    Current Drug Discovery Technologies, Vol. 4, No. 3. (October 2007), pp. 208-219.
  • A Novel Candidate Compound with Urethane Structure for Anticancer Drug Development
    Current Drug Discovery Technologies, Vol. 4, No. 2. (August 2007), pp. 69-76.
    by Atsuko Matsuoka, , Kazuo Isama, , Susumu Tanimura, , Michiaki Kohno, , Takao Yamori,
  • SMILES in QSPR/QSAR Modeling: Results and Perspectives
    Current Drug Discovery Technologies, Vol. 4, No. 2. (August 2007), pp. 77-116.
    by Andrey A Toropov, , Emilio Benfenati,
  • Prediction of MHC Binding Peptides and Epitopes from Alfalfa mosaic virus
    Current Drug Discovery Technologies, Vol. 4, No. 2. (August 2007), pp. 117-125.
    by Virendra S Gomase, , Karbhari V Kale, , Nandkishor J Chikhale, , Smruti S Changbhale,
  • In vivo 19F MR Studies of Fluorine Labeled Photosensitizers in a Murine Tumor Model
    Current Drug Discovery Technologies, Vol. 4, No. 2. (August 2007), pp. 126-132.
    by Subbaraya Ramaprasad, , Elzbieta Ripp, , Joseph Missert, , Ravindra K Pandey,
  • 注: このページを引用する時は次のURLでどうぞ: http://www.citeulike.org/journal/ben-cddt

    Result page: 1 2 3 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.